Option Care Health, Inc. (OPCH)
Full history for every metric is available with a Kvantra account
No price history available.
Key financial summary
Financials in USD| 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | TTM | 2026E | ||
|---|---|---|---|---|---|---|---|---|---|
| Total revenue | $m | 3,033 | 3,439 | 3,945 | 4,302 | 4,998 | 5,650 | 5,694 | 5,753 |
| Operating profit | $m | 338 | 338 | ||||||
| Net profit | $m | -8 | 140 | 151 | 267 | 212 | 208 | 210 | 310 |
| EPS reported | $ | 1.27 | 1.33 | ||||||
| Operating cashflow per share | $ | 1.59 | 2.24 | ||||||
| Capex per share | $ | 0.25 | 0.00 | ||||||
| FCF per share | $ | 1.34 | 2.24 | ||||||
| Free cash flow | $m | 217 | 347 | ||||||
| Net debt | $m | 928 | 965 | ||||||
| Book value equity | $m | 1,326 | 1,260 | ||||||
| Book value per share | $ | 8.12 | 8.09 | ||||||
| Number of shares | m | 163.37 | 155.77 | ||||||
| DPS (TTM paid) | $ | 0.00 | 0.00 |
Financial summary
Financials in USD| 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | TTM | 2026E | ||
|---|---|---|---|---|---|---|---|---|---|
| Value | |||||||||
| P/E TTM | x | 25.09 | 17.35 | ||||||
| P/B LTM | x | 3.89 | 4.10 | ||||||
| P/S LTM | x | 0.91 | 0.91 | ||||||
| P/FCF LTM | x | 23.78 | 14.89 | ||||||
| EV/EBITDA LTM | x | 14.89 | 14.94 | ||||||
| EV/Sales LTM | x | 1.10 | 0.82 | ||||||
| Earnings Yield LTM | % | +3.99% | +5.76% | ||||||
| FCF Yield | % | +4.20% | +6.72% | ||||||
| Quality | |||||||||
| ROE | % | +15.65% | +15.83% | ||||||
| ROIC | % | +9.33% | +9.59% | ||||||
| Operating margin | % | +5.98% | +5.94% | ||||||
| Gross margin | % | +18.06% | +18.17% | ||||||
| FCF/Sales | % | +3.84% | +6.09% | ||||||
| Growth and momentum | |||||||||
| EPS Growth YoY | % | +3.25% | +8.13% | ||||||
| Sales Growth YoY | % | +13.03% | +13.91% | ||||||
| Net Income Growth YoY | % | -2.00% | -1.06% | ||||||
| FCF Growth | % | -24.55% | +20.51% | ||||||
| Operating Profit Growth | % | +4.99% | +5.12% | ||||||
| Dividend and capital structure | |||||||||
| Dividend Yield | % | 0.00% | 0.00% | ||||||
| Dividend Growth | % | - | - | ||||||
| Payout Ratio | % | 0.00% | 0.00% | ||||||
| FCF/Debt | x | 0.17 | 0.27 | ||||||
| Net Debt/EBITDA | x | 2.50 | 2.59 | ||||||
| EBIT/Net interest | x | 5.35 | 5.79 | ||||||
| Net debt/market cap | % | +22.48% | +32.31% | ||||||
| Net debt/Equity | x | 0.70 | 0.77 | ||||||
| Gross debt/equity | x | 0.96 | 1.01 | ||||||
Price target estimates
Based on consensus from external analysts. Not Kvantra's opinion.
Ratings
Based on consensus from external analysts. Not Kvantra's opinion.
ESG
| Metric | 2024 | 2025 | 2026 |
|---|---|---|---|
| ESG-score | |||
| Environmental score | |||
| Social score | |||
| Governance score | |||
| Risk rating |
Company overview
Option Care Health, Inc. delivers infusion services to patients in their homes and other non-hospital settings throughout the United States. The company offers a broad spectrum of specialized infusion treatments, including therapies for various infections, management of heart failure, and comprehensive nutritional support (both intravenous and tube feeding) for individuals with acute or chronic conditions such as stroke, cancer, and digestive illnesses. They also provide immunoglobulin infusions for immune system deficiencies and treatments targeting chronic inflammatory disorders like Crohn's disease, plaque psoriasis, psoriatic arthritis, rheumatoid arthritis, and ulcerative colitis. Furthermore, Option Care Health assists in managing the progression of neurological conditions such as amyotrophic lateral sclerosis (ALS) and Duchenne muscular dystrophy. They also administer infusion therapies for bleeding disorders and provide crucial support for women experiencing high-risk pregnancies. Other specialized infusion services encompass pain relief, chemotherapy, and respiratory care. Complementing these medical offerings, the company provides professional nursing services. Option Care Health, Inc. maintains its primary corporate office in Bannockburn, Illinois.
Similar companies
For informational purposes only. Kvantra provides data and quantitative analysis, not investment advice. KvantraRank is a mechanical model output. Analyst price targets and ratings are sourced from third parties and are not Kvantra recommendations. Past performance does not guarantee future results; all investments carry risk.
No price history available.
Consensus from external analysts. Not Kvantra's opinion.
Based on consensus from external analysts. Not Kvantra's opinion.
Option Care Health, Inc. delivers infusion services to patients in their homes and other non-hospital settings throughout the United States. The company offers a broad spectrum of specialized infusion treatments, including therapies for various infections, management of heart failure, and comprehensive nutritional support (both intravenous and tube feeding) for individuals with acute or chronic conditions such as stroke, cancer, and digestive illnesses. They also provide immunoglobulin infusions for immune system deficiencies and treatments targeting chronic inflammatory disorders like Crohn's disease, plaque psoriasis, psoriatic arthritis, rheumatoid arthritis, and ulcerative colitis. Furthermore, Option Care Health assists in managing the progression of neurological conditions such as amyotrophic lateral sclerosis (ALS) and Duchenne muscular dystrophy. They also administer infusion therapies for bleeding disorders and provide crucial support for women experiencing high-risk pregnancies. Other specialized infusion services encompass pain relief, chemotherapy, and respiratory care. Complementing these medical offerings, the company provides professional nursing services. Option Care Health, Inc. maintains its primary corporate office in Bannockburn, Illinois.
Unlock all fundamental data
Sign up for FreeUnlock all fundamental data
Sign up for Free